SILu(TM)Prot IGFBP7 Insulin-like growth factor-binding protein 7 human

REF : MSST0037-10UG
Marca : Sigma-Aldrich
Descrição :SILu(TM)Prot IGFBP7 Insulin-like growth factor-binding protein 7 human recombinant, expressed in HEK 293 cells, SIL MS Protein Standard, 13C and 15N-labeled
Clique para mais informações
Categoria :
Descrição detalhada : IGFBP7 regulates the availability of insulin-like growth factors (IGFs) in tissue, and modulates IGF binding to its receptors. IGFBP7 binds to IGF with high affinity. Several studies have shown the involvement of IGFBP7 in Acute Kidney Injury (AKI), where its levels can predict patients at risk for developing AKI. When combined with TIMP-2, the accuracy of AKI risk prediction is further increased. Urinary [TIMP-2]x[IGFBP7] test sufficiently detects patients with risk of AKI after major non-cardiac surgery. In addition, Urinary [TIMP-2]x[IGFBP7] serves as a sensitive and specific biomarker to predict AKI early after cardiac surgery and to predict renal recovery.
Sinónimos : IBP-7; IGF-binding protein 7; IGF-bindingprotein7; IGFBP-7; IGFBP-rP1; MAC25 protein; PGI2-stimulating factor; Prostacyclin-stimulating factor; Tumor-derived adhesion factor (TAF)
Armazenamento : -20C
Embalagem : 1X10UG